286 related articles for article (PubMed ID: 34907092)
21. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
Rodríguez D; Gutiérrez-de-Terán H
Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
[TBL] [Abstract][Full Text] [Related]
22. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
Jazayeri A; Dias JM; Marshall FH
J Biol Chem; 2015 Aug; 290(32):19489-95. PubMed ID: 26100628
[TBL] [Abstract][Full Text] [Related]
23. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.
Kortagere S; Welsh WJ
J Comput Aided Mol Des; 2006 Dec; 20(12):789-802. PubMed ID: 17054015
[TBL] [Abstract][Full Text] [Related]
24. Characterizing common substructures of ligands for GPCR protein subfamilies.
Erguner B; Hattori M; Goto S; Kanehisa M
Genome Inform; 2010; 24():31-41. PubMed ID: 22081587
[TBL] [Abstract][Full Text] [Related]
25. FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approach.
Zhou H; Skolnick J
J Chem Inf Model; 2013 Jan; 53(1):230-40. PubMed ID: 23240691
[TBL] [Abstract][Full Text] [Related]
26. Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.
Nguyen ED; Norn C; Frimurer TM; Meiler J
PLoS One; 2013; 8(7):e67302. PubMed ID: 23844000
[TBL] [Abstract][Full Text] [Related]
27. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
Eglen RM; Bosse R; Reisine T
Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
[TBL] [Abstract][Full Text] [Related]
28. Computational methods for studying G protein-coupled receptors (GPCRs).
Kaczor AA; Rutkowska E; Bartuzi D; Targowska-Duda KM; Matosiuk D; Selent J
Methods Cell Biol; 2016; 132():359-99. PubMed ID: 26928552
[TBL] [Abstract][Full Text] [Related]
29. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
Bermudez M; Wolber G
Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
[TBL] [Abstract][Full Text] [Related]
30. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
31. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
32. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S
J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435
[TBL] [Abstract][Full Text] [Related]
33. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.
Jacobson KA; Costanzi S
Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719
[TBL] [Abstract][Full Text] [Related]
34. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
Gruber CW; Muttenthaler M; Freissmuth M
Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
[TBL] [Abstract][Full Text] [Related]
35. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: Ligand Search and Screening.
Luginina AP; Khnykin AN; Khorn PA; Moiseeva OV; Safronova NA; Pospelov VA; Dashevskii DE; Belousov AS; Borschevskiy VI; Mishin AV
Biochemistry (Mosc); 2024 May; 89(5):958-972. PubMed ID: 38880655
[TBL] [Abstract][Full Text] [Related]
36. X-ray structure breakthroughs in the GPCR transmembrane region.
Topiol S; Sabio M
Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
[TBL] [Abstract][Full Text] [Related]
37. Molecular interaction fingerprint approaches for GPCR drug discovery.
Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
[TBL] [Abstract][Full Text] [Related]
38. Revolutionizing GPCR-ligand predictions: DeepGPCR with experimental validation for high-precision drug discovery.
Zhang H; Fan H; Wang J; Hou T; Saravanan KM; Xia W; Kan HW; Li J; Zhang JZH; Liang X; Chen Y
Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38864340
[TBL] [Abstract][Full Text] [Related]
39. Histamine H
Ghamari N; Zarei O; Reiner D; Dastmalchi S; Stark H; Hamzeh-Mivehroud M
Chem Biol Drug Des; 2019 May; 93(5):832-843. PubMed ID: 30586225
[TBL] [Abstract][Full Text] [Related]
40. Target based virtual screening by docking into automatically generated GPCR models.
Tautermann CS
Methods Mol Biol; 2012; 914():255-70. PubMed ID: 22976033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
